Telesis Bio (TBIO) Competitors $0.01 0.00 (-3.33%) As of 10/9/2025 02:06 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsOptions ChainSEC FilingsShort InterestTrendsBuy This Stock TBIO vs. SMIT, SPEC, THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, and KEYSShould you be buying Telesis Bio stock or one of its competitors? The main competitors of Telesis Bio include Schmitt Industries (SMIT), Spectaire (SPEC), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), and Keysight Technologies (KEYS). These companies are all part of the "measuring and control equipment" industry. Telesis Bio vs. Its Competitors Schmitt Industries Spectaire ThermoGenesis HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Schmitt Industries (NASDAQ:SMIT) and Telesis Bio (NASDAQ:TBIO) are both small-cap measuring and control equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends. Which has more volatility and risk, SMIT or TBIO? Schmitt Industries has a beta of -0.44, meaning that its share price is 144% less volatile than the S&P 500. Comparatively, Telesis Bio has a beta of 2.74, meaning that its share price is 174% more volatile than the S&P 500. Does the media refer more to SMIT or TBIO? In the previous week, Schmitt Industries' average media sentiment score of 0.00 equaled Telesis Bio'saverage media sentiment score. Company Overall Sentiment Schmitt Industries Neutral Telesis Bio Neutral Which has better valuation & earnings, SMIT or TBIO? Schmitt Industries has higher earnings, but lower revenue than Telesis Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSchmitt Industries$9.89M0.01-$3.28MN/AN/ATelesis Bio$225.09M0.00-$47.72M-$28.200.00 Do insiders & institutionals hold more shares of SMIT or TBIO? 37.6% of Telesis Bio shares are held by institutional investors. 17.1% of Schmitt Industries shares are held by insiders. Comparatively, 24.5% of Telesis Bio shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is SMIT or TBIO more profitable? Schmitt Industries has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Company Net Margins Return on Equity Return on Assets Schmitt IndustriesN/A N/A N/A Telesis Bio -336.59%N/A -61.89% SummarySchmitt Industries and Telesis Bio tied by winning 4 of the 8 factors compared between the two stocks. Get Telesis Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart TBIO vs. The Competition Export to ExcelMetricTelesis BioAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$21K$1.38M$6.14B$10.65BDividend YieldN/AN/A5.66%4.70%P/E Ratio0.00N/A85.8427.65Price / Sales0.004.56621.93138.22Price / CashN/AN/A38.3262.20Price / Book0.080.0613.066.79Net Income-$47.72M-$54.87M$3.30B$275.88M7 Day PerformanceN/AN/A3.72%1.90%1 Month PerformanceN/AN/A10.70%8.90%1 Year PerformanceN/A-9.64%84.94%36.28% Telesis Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TBIOTelesis BioN/A$0.01-3.3%N/A-99.5%$21K$225.09M0.00200SMITSchmitt IndustriesN/A$0.02flatN/AN/A$57K$9.89M0.00160SPECSpectaireN/A$0.00flatN/AN/A$7KN/A0.008THMOThermoGenesisN/AN/AN/A-99.9%$1K$9.61M0.0040HTGMQHTG Molecular DiagnosticsN/A$0.00flatN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.09-0.3%N/A+12.8%$0.00N/A0.003PRENWPrenetics GlobalN/A$0.03-18.3%N/A+107.4%$0.00$57.05M0.001Negative NewsGap UpQSIAWQuantum-SiN/A$0.33+6.6%N/A+293.9%$0.00$3.41M0.00150Positive NewsGap UpSMAPWSportsMap Tech AcquisitionN/A$0.04+3.5%N/A+15.6%$0.00N/A0.00N/ATTTrane Technologies4.4423 of 5 stars$422.54-0.5%$457.73+8.3%+4.7%$93.95B$20.75B33.4845,000Positive NewsDividend AnnouncementAnalyst ForecastKEYSKeysight Technologies4.4792 of 5 stars$169.95-2.0%$187.38+10.3%+8.2%$29.17B$5.24B54.0615,500Positive NewsAnalyst Forecast Related Companies and Tools Related Companies Schmitt Industries Competitors Spectaire Competitors ThermoGenesis Competitors HTG Molecular Diagnostics Competitors OmniLit Acquisition Competitors Prenetics Global Competitors Quantum-Si Competitors SportsMap Tech Acquisition Competitors Trane Technologies Competitors Keysight Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TBIO) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy…...Crypto 101 Media | SponsoredTrump to get REVENGE on the banks??Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network...The Oxford Club | SponsoredElon callingElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fun...Stansberry Research | SponsoredNvidia and AMD just surged. But this setup was already winning.Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a sin...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telesis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telesis Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
